In terms of prognosis, DHODH was significantly associated with better outcomes in patients with mesothelioma, renal clear cell carcinoma (Supplementary Fig. 1C), and renal papillary cell carcinoma; however, no significant association was found for the prognosis of patients with liver cancer (Fig. 2G, Supplementary Table 1). This evidence concerns the gene DHODH and papillary renal cell carcinoma.